Arzeda

  • About Arzeda
  • Team
  • News
  • Careers
  • About Arzeda
  • Team
  • News
  • Careers

ARZEDA NEWS

Arzeda Ranks #5 in Biofuels Digest’s Annual “Hottest Technologies in the Advanced Bioeconomy” List

11/14/2018

 
Arzeda continues to climb the annual rankings of world’s most widely read biofuels and biobased chemicals daily journal

SEATTLE and SAN FRANCISCO – (November  14, 2018) –Arzeda, the Protein Design Company™, has been recognized for the third time as among the top companies in the advanced bioeconomy in the annual rankings by Biofuels Digest, the world’s most widely-read bioeconomy daily. Arzeda was ranked Number 5 in this year’s 40 Hottest Technologies in the Advanced Bioeconomy list, one step above its number 6 ranking in 2017. Arzeda ranked number 27 on the list in 2016.

Read More

Arzeda and BP Sign Collaborative Joint Development Agreement

10/2/2018

 
SEATTLE and SAN FRANCISCO – (October 2, 2018) –Arzeda, The Protein Design Company™, and BP announced a collaboration to develop a process for producing a renewable chemical with broad applications.

Read More

Arzeda and TeselaGen Partner to Advance Biodesign Technologies for Industrial Biotechnology

10/3/2017

 
Picture
​SEATTLE and SAN FRANCISCO – (October 3, 2017) –Arzeda Corp, “The Protein Design Company™,” and TeselaGen Biotechnology Inc., a software company providing automated DNA design solutions with it’s Synthetic Evolution™ software platform, today announced that Arzeda will license TeselaGen’s proprietary cloud-based informatics solution and collaborate to extend TeselaGen’s state-of-the-art biological design automation platform.

Read More

​Arzeda Raises $12 Million in Series A Round of Funding Led by OS Fund

7/20/2017

 
Picture
Technology scale-up will unlock production of proteins that create sustainable stain-resistant paint, stronger Plexiglas, next-generation sweeteners, and purpose-built molecules that don’t yet exist

SEATTLE, (July 20, 2017) Arzeda, The Protein Design Company™, today announced that it had raised $12 million in a Series A round of funding led by OS Fund and including Bioeconomy Capital and Sustainable Conversion Ventures, as well as a follow-on investment from Arzeda’s seed investor, WRF Capital. Arzeda’s board will be expanded to include Jeff Klunzinger, Co-Founder at OS Fund.


Read More

Gen9 and Arzeda Announce Supply Agreement for Synthetic DNA

4/20/2016

 
Picture
SEATTLE (April 20, 2016) Gen9 and Arzeda today announced an agreement for the supply of megabase quantities of synthetic DNA that will enable Arzeda to accelerate development of novel molecules for its own products as well as those of its partners. The collaboration is part of Gen9’s MAP program, designed to provide industrial users of synthetic DNA with access to game-changing economics for synthetic DNA.

Read More

Arzeda and Zymergen Collaborate on Development of New Molecules

3/21/2016

 
Picture
SEATTLE and EMERYVILLE, Calif. (March 21, 2016) Zymergen and Arzeda announced today a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities.

Read More

Arzeda Agreement with Stratos Genomics for Novel Enzyme Development

11/11/2015

 
Picture
Arzeda will help further develop Stratos’ “Sequencing by Design” technology for rapid single molecule DNA sequencing

SEATTLE, November 11, 2015 – Biotechnology company Arzeda announced today an Agreement with Stratos Genomics to assist development of novel enzymes supporting Stratos’ DNA sequencing technology.

Read More
Forward>>
Copyright © 2021 Arzeda